Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Cardiac AI Monitoring And Diagnostics Market Covering 2025–2034?
The cardiac AI monitoring and diagnostics market has seen substantial growth in recent years. This market is forecast to expand from $1.71 billion in 2024 to $2.14 billion in 2025, achieving a compound annual growth rate (CAGR) of 25.6%. The historical expansion of this market is attributable to several factors, including aging population demographics, an increase in remote patient monitoring, greater healthcare expenditure, numerous clinical research and validation studies, and an enhanced focus on preventive healthcare.
The cardiac ai monitoring and diagnostics market is projected to experience substantial growth in the coming years. By 2029, it is anticipated to reach $5.48 billion, demonstrating a compound annual growth rate (CAGR) of 26.4%. This expansion throughout the forecast period stems from factors such as the proliferation of wearable and IoT devices, the rising acceptance of telemedicine and remote monitoring solutions, the incorporation of big data analytics and predictive modeling, a heightened emphasis on patient-centered care and remote patient engagement, and advancements in healthcare infrastructure. Furthermore, significant trends expected during this period involve the integration of AI with wearable technology, tailored risk assessment and treatment strategies, the application of predictive analytics for cardiovascular incidents, the amalgamation of various data sources, and the establishment of interoperability and data integration standards.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13820&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Cardiac AI Monitoring And Diagnostics Industry?
The escalating incidence of cardiovascular diseases is projected to stimulate the advancement of cardiac AI monitoring and diagnostics moving forward. Cardiovascular diseases (CVDs) represent a spectrum of conditions impacting the heart and blood vessels, encompassing cerebrovascular disease, coronary heart disease, rheumatic heart disease, and others. Cardiac AI monitoring and diagnostics facilitate early detection, risk assessment, and customized therapeutic approaches for cardiovascular ailments, leading to enhanced patient outcomes. For instance, in September 2024, data disseminated by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that around 7.6 million individuals in the UK are afflicted by heart and circulatory diseases, with approximately 4 million males and 3.6 million females living with these conditions. These illnesses contribute to about 27% of all deaths in the UK, accounting for over 170,000 fatalities annually, or roughly 480 deaths each day, which signifies one death every three minutes. Thus, the increasing prevalence of cardiovascular diseases is a key impetus for the cardiac AI monitoring and diagnostics market.
What Are The Primary Types Of Segments Analyzed In The Cardiac AI Monitoring And Diagnostics Market?
The cardiac ai monitoring and diagnosticsmarket covered in this report is segmented –
1) By Type: Cardiac Diagnostics; Cardiac Monitoring
2) By Product: Software; Hardware
3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD); Cardiac Arrhythmias; Ischemic Stroke; Other Applications
4) By End Users: Hospitals; Diagnostic Centers; Other End Users
Subsegments:
1) By Cardiac Diagnostics: ECG Analysis; Echocardiography Analysis; Cardiac Imaging; Biomarker Analysis
2) By Cardiac Monitoring: Wearable Cardiac Monitors; Remote Patient Monitoring Systems; Implantable Cardiac Devices; Continuous ECG Monitoring Systems
What Are The Latest Industry Trends Transforming The Cardiac AI Monitoring And Diagnostics Market?
Leading companies in the cardiac AI monitoring and diagnostics market are concentrating on developing technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to enhance their market standing. Artificial intelligence-based implantable cardiac monitors are devices specifically designed for continuous tracking of cardiac function. For instance, in May 2023, Biotronik, a Germany-based cardiovascular biomedical research and technology company, announced the US Food and Drug Administration (FDA) had approved the BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV implantable cardiac monitor (ICM) integrates BIOTRONIK’s innovative, AI-powered SmartECG algorithm, which utilizes advanced algorithms to eliminate 86% of all false identifications while maintaining 98% of real episodes. This groundbreaking technology improves detection accuracy for healthcare professionals, minimizing false positive warnings and assisting them in making quick and precise diagnoses of certain cardiac problems. Beyond its SmartECG technology, BIOMONITOR IV is also the first ICM to differentiate between premature ventricular contractions (PVCs) and premature atrial contractions (PACs).
Who Are The Core Companies Influencing The Cardiac AI Monitoring And Diagnostics Market Landscape?
Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Cardiac AI Monitoring And Diagnostics Market?
North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Cardiac AI Monitoring And Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13820&type=smp
Browse Through More Reports Similar to the Global Cardiac AI Monitoring And Diagnostics Market 2025, By The Business Research Company
Cardiac Assist Devices And Equipment Global Market Report 2025
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025
Cardiac Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model